Tuesday, September 17, 2024 - 11:00am EDT to Tuesday, September 17, 2024 - 12:00pm EDT
Image
Moderated by: Shireesha Dhanireddy, MD (Medical Director)
Panelists: David Hachey, Pharm.D., AAHIVP; Steven Johnson, MD; Aley Kalapila, MD, PhD, FIDSA
Objectives:
- Discuss optimal timing of antiretroviral (ART) initiation in the setting of an opportunistic infection
- Review cardiovascular risk of ART
- Discuss management of latent TB infection in people on ART
Browse more
Topics
Event type